Om

Metis TechBio Co., Ltd. Class H is a biotechnology company specializing in AI-empowered nanomaterial innovation for drug formulation and delivery. The firm focuses on developing advanced materials and platforms that enable the precise delivery and application of active agents across carbon-based life forms, serving pharmaceutical companies, biotech firms, and medical research institutions in China, the United States, and other markets. Its core technology suite, branded NanoForge, integrates novel lipid libraries, AI foundational models, quantum chemistry, molecular dynamics simulations, and AI-driven screening to design and optimize nanomaterials and their therapeutic payloads. Metis TechBio also operates specialized platforms such as AiLNP for nano delivery systems, AiRNA for mRNA sequence design, and AiTEM for small-molecule formulation, targeting applications in areas including oncology, metabolic, autoimmune, and neurodegenerative conditions. Headquartered in Beijing and founded in 2020, Metis TechBio Co., Ltd. Class H plays a distinct role in the healthcare and biotechnology sectors by providing AI-based formulation and delivery solutions that support the development of next-generation biopharmaceutical products.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I METIS TECHBIO CO MED ENDAVU: Køb Metis TechBio Co ($7666) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Metis TechBio Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.